NCT02489890View on ClinicalTrials.gov

CIK in Treating Patients With Bladder Cancer

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

1,500

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2030

Conditions
Urinary Bladder Neoplasms
Interventions
BIOLOGICAL

Cytokine-induced Killer Cells

chemotherapy plus 3 cycles of Cytokine-induced Killer Cells(CIK) treatment

All Listed Sponsors
lead

The First People's Hospital of Changzhou

OTHER